Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics

This study is aimed at assessing the impact of soluble dietary fiber inulin on the treatment of diabetes-related chronic inflammation and kidney injury in mice with type 2 diabetes (T2DM). The T2DM model was created by feeding the Institute of Cancer Research (ICR) mice a high-fat diet and intraperi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiayuan He, Xiang Li, Man Yan, Xinsheng Chen, Chang Sun, Jiajun Tan, Yinsheng Song, Hong Xu, Liang Wu, Zhengnan Yang
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2024/1222395
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553213672292352
author Jiayuan He
Xiang Li
Man Yan
Xinsheng Chen
Chang Sun
Jiajun Tan
Yinsheng Song
Hong Xu
Liang Wu
Zhengnan Yang
author_facet Jiayuan He
Xiang Li
Man Yan
Xinsheng Chen
Chang Sun
Jiajun Tan
Yinsheng Song
Hong Xu
Liang Wu
Zhengnan Yang
author_sort Jiayuan He
collection DOAJ
description This study is aimed at assessing the impact of soluble dietary fiber inulin on the treatment of diabetes-related chronic inflammation and kidney injury in mice with type 2 diabetes (T2DM). The T2DM model was created by feeding the Institute of Cancer Research (ICR) mice a high-fat diet and intraperitoneally injecting them with streptozotocin (50 mg/kg for 5 consecutive days). The thirty-six ICR mice were divided into three dietary groups: the normal control (NC) group, the T2DM (DM) group, and the DM + inulin diet (INU) group. The INU group mice were given inulin at the dose of 500 mg/kg gavage daily until the end of the 12th week. After 12 weeks, the administration of inulin resulted in decreased serum levels of fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL-C), blood urea nitrogen (BUN), and creatinine (CRE). The administration of inulin not only ameliorated renal injury but also resulted in a reduction in the mRNA expressions of inflammatory factors in the spleen and serum oxidative stress levels, when compared to the DM group. Additionally, inulin treatment in mice with a T2DM model led to a significant increase in the concentrations of three primary short-chain fatty acids (SCFAs) (acetic acid, propionic acid, and butyric acid), while the concentration of advanced glycation end products (AGEs), a prominent inflammatory factor in diabetes, exhibited a significant decrease. The results of untargeted metabolomics indicate that inulin has the potential to alleviate inflammatory response and kidney damage in diabetic mice. This beneficial effect is attributed to its impact on various metabolic pathways, including glycerophospholipid metabolism, taurine and hypotaurine metabolism, arginine biosynthesis, and tryptophan metabolism. Consequently, oral inulin emerges as a promising treatment option for diabetes and kidney injury.
format Article
id doaj-art-9fef8cc07dac45359d08db0ea9544970
institution Kabale University
issn 2314-6753
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-9fef8cc07dac45359d08db0ea95449702025-02-03T05:54:35ZengWileyJournal of Diabetes Research2314-67532024-01-01202410.1155/2024/1222395Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum MetabolomicsJiayuan He0Xiang Li1Man Yan2Xinsheng Chen3Chang Sun4Jiajun Tan5Yinsheng Song6Hong Xu7Liang Wu8Zhengnan Yang9Health Testing CenterMedical Laboratory DepartmentDepartment of Laboratory MedicineHospital Infection-Disease Control DepartmentDepartment of Laboratory MedicineDepartment of Laboratory MedicineHealth Testing CenterHealth Testing CenterDepartment of Laboratory MedicineDepartment of Clinical LaboratoryThis study is aimed at assessing the impact of soluble dietary fiber inulin on the treatment of diabetes-related chronic inflammation and kidney injury in mice with type 2 diabetes (T2DM). The T2DM model was created by feeding the Institute of Cancer Research (ICR) mice a high-fat diet and intraperitoneally injecting them with streptozotocin (50 mg/kg for 5 consecutive days). The thirty-six ICR mice were divided into three dietary groups: the normal control (NC) group, the T2DM (DM) group, and the DM + inulin diet (INU) group. The INU group mice were given inulin at the dose of 500 mg/kg gavage daily until the end of the 12th week. After 12 weeks, the administration of inulin resulted in decreased serum levels of fasting blood glucose (FBG), low-density lipoprotein cholesterol (LDL-C), blood urea nitrogen (BUN), and creatinine (CRE). The administration of inulin not only ameliorated renal injury but also resulted in a reduction in the mRNA expressions of inflammatory factors in the spleen and serum oxidative stress levels, when compared to the DM group. Additionally, inulin treatment in mice with a T2DM model led to a significant increase in the concentrations of three primary short-chain fatty acids (SCFAs) (acetic acid, propionic acid, and butyric acid), while the concentration of advanced glycation end products (AGEs), a prominent inflammatory factor in diabetes, exhibited a significant decrease. The results of untargeted metabolomics indicate that inulin has the potential to alleviate inflammatory response and kidney damage in diabetic mice. This beneficial effect is attributed to its impact on various metabolic pathways, including glycerophospholipid metabolism, taurine and hypotaurine metabolism, arginine biosynthesis, and tryptophan metabolism. Consequently, oral inulin emerges as a promising treatment option for diabetes and kidney injury.http://dx.doi.org/10.1155/2024/1222395
spellingShingle Jiayuan He
Xiang Li
Man Yan
Xinsheng Chen
Chang Sun
Jiajun Tan
Yinsheng Song
Hong Xu
Liang Wu
Zhengnan Yang
Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
Journal of Diabetes Research
title Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
title_full Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
title_fullStr Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
title_full_unstemmed Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
title_short Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
title_sort inulin reduces kidney damage in type 2 diabetic mice by decreasing inflammation and serum metabolomics
url http://dx.doi.org/10.1155/2024/1222395
work_keys_str_mv AT jiayuanhe inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT xiangli inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT manyan inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT xinshengchen inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT changsun inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT jiajuntan inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT yinshengsong inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT hongxu inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT liangwu inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics
AT zhengnanyang inulinreduceskidneydamageintype2diabeticmicebydecreasinginflammationandserummetabolomics